Adagio Medical Holdings, Inc. (ADGM)

NCM – Цена в реальном времени. Валюта: USD

0.69

-0.03 (-4.17%)

Рынок открыт: Aug 12, 2026, 11:36 AM EDT

0.70

-0.02 (-2.93%)

Предыдущая сессия: Aug 11, 2026, 7:54 PM EDT

11.08.2026

Adagio Medical Reports Second Quarter 2026 Results

LAGUNA HILLS, Calif.--(BUSINESS WIRE)---- $ADGM #ARRHYTHMIA--Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced financial results for the second quarter ended June 30, 2026. Recent Business Highlights: Announced the successful treatment at the Hospital of University of Pennsylvania of the first patient with the Company's next-generation vCLAS™ Ultra Ultra-Low temperature ablation cat.

03.08.2026

Adagio Medical Treats First Patient with Faster, Single-Freeze Next-Generation ULTA System

LAGUNA HILLS, Calif.--(BUSINESS WIRE)---- $ADGM #ARRHYTHMIA--Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced the successful treatment of the first patient with its next-generation vCLAS Ultra Ultra-Low Temperature Ablation (“ULTA”) system under Expanded Access authorization from the U.S. Food and Drug Administration (“FDA”).The patient, who presented with non-ischemic cardiomyopath.

Видео

No Data

There is no data to display

Пресс-релизы

11.08.2026

Adagio Medical Reports Second Quarter 2026 Results

03.08.2026

Adagio Medical Treats First Patient with Faster, Single-Freeze Next-Generation ULTA System

LAGUNA HILLS, Calif.--(BUSINESS WIRE)---- $ADGM #ARRHYTHMIA--Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced the successful treatment of the first patient with its next-generation vCLAS Ultra Ultra-Low Temperature Ablation (“ULTA”) system under Expanded Access authorization from the U.S. Food and Drug Administration (“FDA”).The patient, who presented with non-ischemic cardiomyopath.

Adagio Medical Holdings, Inc. (ADGM)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Adagio Medical Holdings, Inc. (ADGM)

Adagio Medical Reports Second Quarter 2026 Results

Adagio Medical Treats First Patient with Faster, Single-Freeze Next-Generation ULTA System

Видео

No Data

Пресс-релизы

Adagio Medical Reports Second Quarter 2026 Results

Adagio Medical Treats First Patient with Faster, Single-Freeze Next-Generation ULTA System

Adagio Medical Reports Second Quarter 2026 Results

Adagio Medical Treats First Patient with Faster, Single-Freeze Next-Generation ULTA System

Видео

No Data

Пресс-релизы

Adagio Medical Reports Second Quarter 2026 Results

Adagio Medical Treats First Patient with Faster, Single-Freeze Next-Generation ULTA System

Search stocks

Adagio Medical Holdings, Inc. (ADGM)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Adagio Medical Holdings, Inc. (ADGM)

Adagio Medical Reports Second Quarter 2026 Results

Adagio Medical Treats First Patient with Faster, Single-Freeze Next-Generation ULTA System

Видео

No Data

Пресс-релизы

Adagio Medical Reports Second Quarter 2026 Results

Adagio Medical Treats First Patient with Faster, Single-Freeze Next-Generation ULTA System

Adagio Medical Reports Second Quarter 2026 Results

Adagio Medical Treats First Patient with Faster, Single-Freeze Next-Generation ULTA System

Видео

No Data

Пресс-релизы

Adagio Medical Reports Second Quarter 2026 Results

Adagio Medical Treats First Patient with Faster, Single-Freeze Next-Generation ULTA System